Showing results (301-310 of 319) with videos related to
Sort By:
Pageof 32
Atmospheric Chemistry and Physics|January 11, 2021
The first evaluation of formaldehyde column observations by improved Pandora spectrometers during the KORUS-AQ field studyElena Spinei, Andrew Whitehill, Alan Fried, et al.Nature Communications|June 12, 2024
Ribosomal DNA copy number is associated with body mass in humans and other mammalsPui Pik Law, Liudmila A Mikheeva, Francisco Rodriguez-Algarra, et al.European Stroke Journal|April 25, 2026
Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trialLouise Maes, Claudia Verschuere, Cathal Walsh, et al.Patient Preference and Adherence|August 6, 2015
Perspectives of patients on factors relating to adherence to post-acute coronary syndrome medical regimensAnne Lambert-Kerzner, Edward P Havranek, Mary E Plomondon, et al.European Radiology|August 2, 2025
Agreement across different measurements for internal carotid artery stenosis in patients with TIA or stroke in the CONVINCE trialLouise Maes, Jo P Peluso, Joseph Benzakoun, et al.Journal of Tissue Engineering|November 11, 2014
Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot studyBenjamin M Davies, Sarah Rikabi, Anna French, et al.Stroke|January 18, 2020
A Risk Score Including Carotid Plaque Inflammation and Stenosis Severity Improves Identification of Recurrent StrokePeter J Kelly, Pol Camps-Renom, Nicola Giannotti, et al.The Lancet. Global Health|January 20, 2023
A global core outcome measurement set for snakebite clinical trialsMichael Abouyannis, Hanif Esmail, Mainga Hamaluba, et al.Medecine Tropicale Et Sante Internationale|December 14, 2023
[A global core outcome measurement set for snakebite clinical trials]Michael Abouyannis, Hanif Esmail, Mainga Hamaluba, et al.Lancet (London, England)|June 10, 2024
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trialPeter Kelly, Robin Lemmens, Christian Weimar, et al.Pageof 32